共 28 条
- [1] Cooperberg MR(2004)The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CapSURE), a national disease registry J Urol 171 1393-1401
- [2] Broering JM(2011)Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin’s lymphoma Nat Med 17 941-943
- [3] Litwin MS(2007)Bladder cancer incidence and risk factors in men with prostate cancer: results from cancer of the prostate strategic urologic research endeavor J Urol 177 883-887
- [4] Best T(2006)Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up Int J Radiat Oncol Biol Phys 66 669-673
- [5] Li D(2019)Predictive biomarkers for drug response in bladder cancer Int J Urol 26 1044-1053
- [6] Skol AD(2006)Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer BJU Int 98 59-62
- [7] Boorjian S(2010)Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer J Urol 183 1751-1756
- [8] Cowan JE(undefined)undefined undefined undefined undefined-undefined
- [9] Konety BR(undefined)undefined undefined undefined undefined-undefined
- [10] Liauw SL(undefined)undefined undefined undefined undefined-undefined